Across race, income, gender, and geography, we agree that the state needs to step up and help more Minnesotans access affordable, quality healthcare. Medical emergencies happen to everyone, and everybody deserves access to healthcare, no matter what. Nobody should have to sacrifice paying for rent or groceries to get the care they need.
MinnesotaCare (MNCare) was created by bipartisan leadership in 1992 to provide health insurance to low-income, working Minnesotans. In 2020, approximately 92,000 Minnesotans are enrolled in MNCare for high-quality, lower-cost health
Altarum Healthcare Value Hub released results from a new survey that looks specifically at how affordability concerns and ideas for action play out in Minnesota.
Happy Monday! We have a big week ahead of us at the State Capitol: On Tuesday, January 25th, the Health Finance and Policy Committee will hold its first hearing of
Today, thousands of Minnesotans are excluded from health care coverage because of their immigration status. Across the state, thousands of Minnesotans including farmers, small business owners, artists, and young families
My name is Kenza and I’m the public affairs director at TakeAction Minnesota. Today is the first day of the 2021 legislative session. We are thrilled to start this incredibly
Drugs don’t work if people can’t afford them. We all pay the price of out of control drug costs at the pharmacy and through health insurance premiums. Join TakeAction Minnesota
Contact: Kenza Hadj-Moussa, 612-386-9556 NEWS RELEASE TakeAction Minnesota releases new podcast on prescription drug prices (St. Paul, MN)—At some point, nearly all of us will need a prescription drug to
CONTACT: Kenza Hadj-Moussa, 612-386-9556 MEDIA ADVISORY TakeAction Minnesota to release new podcast on prescription drug prices WHAT: Three part podcast series Action Prescribed exploring why prescription drug prices are out
No matter our age, race, or zip code, everyone deserves access to affordable medicine. Life and health should not be for sale.
As the entire world waits for an effective COVID-19 vaccine, we recognize that access and distribution of the medicine will be one of the country’s biggest ethical challenges. Pharmaceutical corporations, as we know, have no issue price-gouging life saving medicine developed with public funding.
